Linda J Pike

Title: Linda J Pike - Innovator in Tyrosine Kinase Inhibitors

Introduction

Linda J Pike is a prominent inventor based in Clayton, MO (US). She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for tyrosine kinase receptors. Her innovative work has implications for cancer treatment and other medical applications.

Latest Patents

Linda J Pike holds a patent for "Inhibitors of Tyrosine Kinase Receptor Dimerization." This patent outlines methods for identifying inhibitors that prevent the dimerization of receptor tyrosine kinases (RTKs) such as EGFR. The methods involve using a digital computer to create a molecular model of the extracellular dimerization domains of RTKs. By docking chemical databases to this model and scoring the compounds, high-scoring inhibitors can be identified. The patent also details in vitro testing for RTK inhibitory activity and specificity. Notably, two compounds, NSC11241 and NSC56452, have been disclosed for their ability to inhibit EGF receptor kinase activation in a dose-dependent manner.

Career Highlights

Linda J Pike is affiliated with Washington University, where she continues her research and development in the field of biochemistry. Her work has garnered attention for its potential to advance therapeutic strategies against various diseases.

Collaborations

Linda has collaborated with notable colleagues such as Garland R Marshall and Robert Yang, contributing to the advancement of research in her field.

Conclusion

Linda J Pike's innovative work in the development of tyrosine kinase inhibitors showcases her dedication to advancing medical science. Her contributions are vital for future therapeutic developments.